BRPI1014382A2 - inibidor de reabsorção de serotonina e norepinefrina, seu uso e composição farmacêutica - Google Patents
inibidor de reabsorção de serotonina e norepinefrina, seu uso e composição farmacêuticaInfo
- Publication number
- BRPI1014382A2 BRPI1014382A2 BRPI1014382A BRPI1014382A BRPI1014382A2 BR PI1014382 A2 BRPI1014382 A2 BR PI1014382A2 BR PI1014382 A BRPI1014382 A BR PI1014382A BR PI1014382 A BRPI1014382 A BR PI1014382A BR PI1014382 A2 BRPI1014382 A2 BR PI1014382A2
- Authority
- BR
- Brazil
- Prior art keywords
- serotonin
- pharmaceutical composition
- reuptake inhibitor
- norepinephrine reuptake
- norepinephrine
- Prior art date
Links
- 229940121991 Serotonin and norepinephrine reuptake inhibitor Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16807909P | 2009-04-09 | 2009-04-09 | |
| PCT/US2010/030038 WO2010117979A2 (en) | 2009-04-09 | 2010-04-06 | Serotonin and norepinephrine reuptake inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1014382A2 true BRPI1014382A2 (pt) | 2016-04-05 |
Family
ID=42698378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1014382A BRPI1014382A2 (pt) | 2009-04-09 | 2010-04-06 | inibidor de reabsorção de serotonina e norepinefrina, seu uso e composição farmacêutica |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8173821B2 (enExample) |
| EP (1) | EP2417124B1 (enExample) |
| JP (1) | JP2012523416A (enExample) |
| KR (1) | KR101378260B1 (enExample) |
| CN (1) | CN102388036A (enExample) |
| AR (1) | AR075988A1 (enExample) |
| AU (1) | AU2010234610B2 (enExample) |
| BR (1) | BRPI1014382A2 (enExample) |
| CA (1) | CA2758251C (enExample) |
| EA (1) | EA201171230A1 (enExample) |
| ES (1) | ES2446644T3 (enExample) |
| MX (1) | MX2011010658A (enExample) |
| TW (1) | TW201103908A (enExample) |
| WO (1) | WO2010117979A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2434250T3 (es) | 2008-07-24 | 2013-12-16 | Theravance, Inc. | Compuestos de 3-(fenoxifenilmetil)pirrolidina |
| JP2012524098A (ja) * | 2009-04-15 | 2012-10-11 | セラヴァンス， インコーポレーテッド | ３−（フェノキシピロリジン−３−イル−メチル）ヘテロアリール、３−（フェニルピロリジン−３−イルメトキシ）ヘテロアリールおよび３−（ヘテロアリールピロリジン−３−イルメトキシ）ヘテロアリール化合物 |
| EP2454234B1 (en) * | 2009-07-13 | 2018-04-11 | Theravance Biopharma R&D IP, LLC | 3-phenoxymethylpyrrolidine compounds |
| ES2495366T3 (es) | 2009-07-21 | 2014-09-17 | Theravance, Inc. | Compuestos de 3-fenoximetilpirrolidina |
| US8471040B2 (en) | 2010-10-11 | 2013-06-25 | Theravance, Inc. | Serotonin reuptake inhibitors |
| WO2012075239A1 (en) | 2010-12-03 | 2012-06-07 | Theravance, Inc. | Serotonin reuptake inhibitors |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL1004346C2 (nl) | 1996-10-23 | 1998-04-24 | Dsm Nv | Werkwijze voor het scheiden van een mengsel van enantiomeren in een geschikt oplosmiddel. |
| WO1998025920A1 (en) | 1996-12-10 | 1998-06-18 | Abbott Laboratories | 3-pyridyl enantiomers and their use as analgesics |
| WO1999032480A1 (en) | 1997-12-19 | 1999-07-01 | Abbott Laboratories | Heterocyclic ether and thioether compounds useful in controlling chemical synaptic transmission |
| US20020151712A1 (en) * | 1999-09-14 | 2002-10-17 | Nan-Horng Lin | 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission |
| JP2003529547A (ja) | 1999-09-14 | 2003-10-07 | アボット・ラボラトリーズ | 化学シナプス伝達のコントロールに有効な３−ピロリジニルオキシ−３’−ピリジルエーテル化合物 |
| MXPA06012505A (es) | 2004-04-30 | 2006-12-15 | Warner Lambert Co | Compuestos de morfolina sustituida para el tratamiento de trastornos del sistema nervioso central. |
| MX2009002000A (es) | 2006-08-23 | 2009-03-06 | Pfizer Prod Inc | Derivados de piperidina. |
| ES2374952T3 (es) | 2006-12-06 | 2012-02-23 | Glaxosmithkline Llc | Compuestos bicíclicos y uso como antidiabéticos. |
| ES2434250T3 (es) | 2008-07-24 | 2013-12-16 | Theravance, Inc. | Compuestos de 3-(fenoxifenilmetil)pirrolidina |
-
2010
- 2010-03-29 AR ARP100101017A patent/AR075988A1/es unknown
- 2010-04-02 TW TW099110421A patent/TW201103908A/zh unknown
- 2010-04-06 CN CN2010800160763A patent/CN102388036A/zh active Pending
- 2010-04-06 KR KR1020117023570A patent/KR101378260B1/ko not_active Expired - Fee Related
- 2010-04-06 CA CA2758251A patent/CA2758251C/en not_active Expired - Fee Related
- 2010-04-06 US US12/754,800 patent/US8173821B2/en not_active Expired - Fee Related
- 2010-04-06 MX MX2011010658A patent/MX2011010658A/es active IP Right Grant
- 2010-04-06 ES ES10713753.1T patent/ES2446644T3/es active Active
- 2010-04-06 JP JP2012504759A patent/JP2012523416A/ja active Pending
- 2010-04-06 EA EA201171230A patent/EA201171230A1/ru unknown
- 2010-04-06 BR BRPI1014382A patent/BRPI1014382A2/pt not_active IP Right Cessation
- 2010-04-06 AU AU2010234610A patent/AU2010234610B2/en not_active Ceased
- 2010-04-06 WO PCT/US2010/030038 patent/WO2010117979A2/en not_active Ceased
- 2010-04-06 EP EP10713753.1A patent/EP2417124B1/en not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| TW201103908A (en) | 2011-02-01 |
| KR101378260B1 (ko) | 2014-03-27 |
| WO2010117979A2 (en) | 2010-10-14 |
| US8173821B2 (en) | 2012-05-08 |
| CA2758251A1 (en) | 2010-10-14 |
| CA2758251C (en) | 2013-08-06 |
| JP2012523416A (ja) | 2012-10-04 |
| WO2010117979A3 (en) | 2011-02-17 |
| AU2010234610B2 (en) | 2013-04-18 |
| MX2011010658A (es) | 2011-10-21 |
| US20100261762A1 (en) | 2010-10-14 |
| ES2446644T3 (es) | 2014-03-10 |
| CN102388036A (zh) | 2012-03-21 |
| EP2417124A2 (en) | 2012-02-15 |
| EA201171230A1 (ru) | 2012-03-30 |
| EP2417124B1 (en) | 2013-12-18 |
| AU2010234610A1 (en) | 2011-10-06 |
| AR075988A1 (es) | 2011-05-11 |
| KR20110123287A (ko) | 2011-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1009372A2 (pt) | compostos, composição farmacêutica e respectivos usos | |
| BRPI1010621A2 (pt) | derivado de imidazoquinolinonas, sua composição farmacêutica e seu uso | |
| BRPI1007018A2 (pt) | composto, composição farmacêutica, e , uso de um composto. | |
| BRPI1016219A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI1008793A2 (pt) | composto, uso de um composto, e, composição farmacêutica | |
| BRPI1008906A2 (pt) | composto, composição farmacêutica, e, uso de um composto. | |
| BR112013016772A2 (pt) | composto, uso do composto, composição farmacêutica, oligonucleotídeo e conjugado | |
| DK3097925T3 (da) | Farmaceutisk sammensætning | |
| BRPI0906962A2 (pt) | Composto, e, composição farmacêutica | |
| BRPI0906556A2 (pt) | Composto, e, composição farmacêutica | |
| BRPI1012892A2 (pt) | composto, e, composição farmacêutica. | |
| BRPI1004940A2 (pt) | composição farmacêutica | |
| SMT201700095B (is) | Composizioni farmaceutiche per inalazione | |
| BR112012003842A2 (pt) | composição farmacêutica, método de formulação e uso da mesma | |
| BR112012004335A2 (pt) | composto, composição farmacêutica, e, uso do composto. | |
| BRPI1015939A2 (pt) | composição farmacêutica | |
| BR112012031226A2 (pt) | composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica | |
| BRPI0917681A2 (pt) | Composto, e, composição farmacêutica | |
| DK2391349T3 (da) | Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater | |
| BRPI1009757A2 (pt) | composto, composição farmacêutica, e , uso de um composto. | |
| DK2285413T3 (da) | Farmaceutisk sammensætning | |
| BR112012000831A2 (pt) | compostos, composições farmacêuticas e métodos relacionados | |
| BRPI1011412A2 (pt) | composição para liberação sustentada de droga compreendendo alutinante geopolimérico | |
| BRPI1006953A2 (pt) | composição farmacêutica, e, uso de uma composição | |
| BRPI0920862A2 (pt) | composição, método para fabricação da mesma, e uso da mesma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A E 6A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |